CORVUS PHARMACEUTICALS
8.8000
07-November-24 15:59:59
15 minutes delayed
Stocks
+0.0200
+0.23%
Today's range
8.4300 - 9.1000
ISIN
N/A
Source
NASDAQ
-
17 May 2023 09:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
08 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
20 Apr 2023 09:00:01 By Nasdaq GlobeNewswire
-
03 Apr 2023 08:30:00 By Nasdaq GlobeNewswire
-
28 Mar 2023 16:02:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
21 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
12 Dec 2022 10:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022
05 Dec 2022 08:30:00 By Nasdaq GlobeNewswire
-
James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology
14 Nov 2022 08:30:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
03 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
03 Nov 2022 09:52:48 By Nasdaq GlobeNewswire
-
27 Oct 2022 16:05:01 By Nasdaq GlobeNewswire
-
25 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
08 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
28 Jul 2022 16:05:01 By Nasdaq GlobeNewswire